Amyloid-β associated volume loss occurs only in the presence of phospho-tau. - Wikidata - awgldk - TriplyDB

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

http://www.wikidata.org/entity/Q36010484

about

The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data.Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models.Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration.Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.An expanded role for neuroimaging in the evaluation of memory impairment.The role of clusterin in amyloid-β-associated neurodegeneration.Should we disclose amyloid imaging results to cognitively normal individuals?Rates of decline in Alzheimer disease decrease with age.Enrichment and stratification for predementia Alzheimer disease clinical trials.The evolution of preclinical Alzheimer's disease: implications for prevention trials.What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease Toward a multifactorial model of Alzheimer disease.Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau.Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough.NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss.CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade.White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer's disease Is amyloid-β harmful to the brain? Insights from human imaging studies The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.Heart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration.Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer's disease.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Biomarker modeling of Alzheimer's disease.Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease.A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults.Interaction between pathogenic proteins in neurodegenerative disorders.Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

P2860

Q26830467-91ECACBE-3A27-400D-9137-B27AC9C6DD56 Q28577666-FD424F59-1AE2-40EE-824D-0F2002837D94 Q30486156-D0FE5F72-A12C-41A8-BA85-21E79A8F93F0 Q30576007-70F96FDD-8B4F-4883-BF40-FBDB48B29FD8 Q30773959-F17902C8-D93A-4E1F-9970-E0A86E7DF94C Q30981669-44E6443B-0BDE-4F54-90F8-995BBFA686C3 Q33581412-DD0787D2-02CE-46B9-AB4F-02410055B7FF Q33699415-A7D0C196-4522-4134-BCE0-C37C7C103740 Q33830698-1B15DECA-084F-4DFC-84D7-E70828CFAF0A Q33988464-FF54EABC-39FE-4EB0-9EB4-406D1635C01D Q34286140-F9DD963D-E71E-441E-BDBB-312D32B83D3C Q34372593-6EF3D40E-CF92-436B-8862-A0C29B46B1A6 Q34452239-21888FCF-6608-46AC-A7D2-C9A5EF801DF8 Q34849048-239D33FF-377F-44D2-8B33-4952031F22F0 Q35129501-762AB67F-B9D4-40BE-BE1E-64BB1B26840C Q35195654-B4C7394D-3C25-45B3-86E2-DCEFA91DC2A1 Q35643397-EF56585C-9055-4833-996B-2D207CDFEF60 Q35907226-201103AA-4DFE-4B2E-8007-610FF44950D3 Q35963497-89436019-508C-4D91-B287-67EB2424713E Q36143793-55126A88-E28C-4194-A537-1A90E36B8665 Q36177140-4F3B3839-719B-48D7-AAE6-764031E6747A Q36612922-FB02DC84-7326-42D3-A4FD-74B79BE99176 Q36809558-AD23EE07-2B7B-4163-AACE-8F39C3276079 Q36851017-65F8577F-0DC0-4E07-A12F-625AC9776FF0 Q36874831-897BF95C-372F-4358-8214-8A01B0627889 Q36934113-25645873-51B7-4182-A20B-F1DB3B455446 Q37054759-B0FE7A8A-B88D-4116-AF14-66716473D0A1 Q37188315-3BF40608-1557-452F-9E26-9BA98EBFB8CB Q37297360-C1D6C36F-F5CD-40E2-B585-14039CCE08DB Q37363347-8645FF9F-5A94-427F-9A32-40AC37996932 Q37448226-608D1CF0-BF98-48BF-B410-0C63D3E97485 Q37449999-FEB14690-E65C-457F-B64D-3C2EB1EB44E8 Q37524486-8D286327-3DE8-4913-AA80-F5E22EA468F9 Q37592824-0D815BCB-F801-4363-A79A-83CCCCD89E86 Q37603879-D6431157-2655-4545-B3F6-2EE84508DFFE Q37635614-F58AEB1E-EC7B-4DB9-8504-4927344C1C40 Q37681181-8CD692E3-52B0-4F39-AEB8-CAEB5862E4E8 Q37969262-7DAB5EB6-C78C-4EBA-90AF-1C0C5DFFC425 Q37971458-22C684B8-16E0-4F34-8706-25B18E403409 Q38741683-E9702520-9FB5-4F5F-BA1A-4F6447410E90

P2860

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

http://www.wikidata.org/entity/Q36010484

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

@ast

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

@en

type

label

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

@ast

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

@en

prefLabel

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

@ast

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

@en

P1433

Q36010484-EF4077C8-68D4-4DDB-9723-73EA512EC2F3

P1476

Q36010484-B954E8D1-223F-4788-B631-94A8CD4779B1

P2093

Q36010484-040F6A46-08C7-4524-8A53-47990BCEB16F

Q36010484-2E9345BF-49C6-4B6A-8BD2-29C2BBD0A439

Q36010484-7FDE84FA-A7EC-46EC-A50F-227CAB4AA2A9

Q36010484-CBB24CE9-3901-47C0-B2AD-FF8238D62FAD

Q36010484-F00467E8-DE5D-43CC-9942-7DA5EE71EDF5

P2860

Q36010484-00B9E765-3D44-4FEC-A708-192E594817E6

Q36010484-25081938-EEF4-412F-A236-6C4CAB3AE2EC

Q36010484-27937019-1167-4053-B69F-755D595F142F

Q36010484-3142E4FB-3E01-4713-922C-BB469824B7EA

Q36010484-40663FC3-2049-4685-8B27-F317C8B3FBBE

Q36010484-45FDCFF2-D380-41D2-933F-E7D26AED42C3

Q36010484-4BC79075-1574-49FD-A856-00910482329C

Q36010484-5D237993-BD1F-48D1-85D9-DE70FBC840CC

Q36010484-7760E42D-0C83-4AD7-8015-D21500E71CB7

Q36010484-79F57EF1-CB51-4A59-A3C4-30DC4E6B512C

P304

Q36010484-2220A7B5-4A9F-443F-BD55-9CADBE6B9AE5

P31

Q36010484-5804524F-53C1-4529-BC86-31F6D7AC4CC2

P356

Q36010484-68729520-D00F-47C0-BC0E-A8AD18446DFA

P433

Q36010484-50F7E2D7-BBF0-40FD-8C7C-3279F15A45ED

P478

Q36010484-C800A68F-7019-4BB4-B1EE-90D88D902B5C

P50

Q36010484-182F0041-4B53-4F08-B652-9B3510C6E0A8

Q36010484-1A84DD99-E94A-4BAC-BBC6-E2F90820E454

Q36010484-4D48E4CC-9742-4212-A2C3-673FF8976F59

Q36010484-8ADDFB59-4609-4335-BCB0-01683B73164C

Q36010484-90173715-17C0-4401-BE76-3CC3688A4176

Q36010484-D526DFE2-EB6C-4D22-B5EF-64E118978048

P577

Q36010484-DA8C84EE-5F60-4950-8107-0BCA8BC152F1

P5875

Q36010484-235A2AEB-B705-4683-80FD-EBF976B65650

P698

Q36010484-BB2E0D57-BA7A-46D9-AE31-F300E3F1BB77

P932

Q36010484-859573FB-527F-4CE3-AE20-8A3DB7763EC7

P356

P1433

Annals of Neurology

P1476

Amyloid-β associated volume loss occurs only in the presence of phospho-tau.

@en

P2093

J Cooper Roddey

http://www.w3.org/2001/XMLSchema#string

James B Brewer

http://www.w3.org/2001/XMLSchema#string

Linda K McEvoy

http://www.w3.org/2001/XMLSchema#string

Rahul S Desikan

http://www.w3.org/2001/XMLSchema#string

Wesley K Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

Total and phosphorylated tau protein as biological markers of Alzheimer's disease.

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.

Nonlinear registration of longitudinal images and measurement of change in regions of interest

Amyloid-β associated cortical thinning in clinically normal elderly.

Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

P304

657-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.22509

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

Dominic Holland

P577

2011-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51724102

http://www.w3.org/2001/XMLSchema#string

P698

22002658

http://www.w3.org/2001/XMLSchema#string

P932

3368003

http://www.w3.org/2001/XMLSchema#string